Skip to content

Clinical trials

Completed Heart Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Status: Completed Country / region: South Korea Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20111
20121
20131
20142
20171
20181
20191
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
HUINNO Co., Ltd2
Seung-Jung Park2
AstraZeneca1
Bayer1
Byung-Hee Oh1
CSL Behring1
Chonnam National University Hospital1
Eidos Therapeutics, a BridgeBio company1
Hallym University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases15
Cardiovascular Diseases7
Coronary Disease5
Acute Coronary Syndrome4
Coronary Artery Disease4
Atherosclerosis3
Myocardial Infarction3
Stroke3
Angina Pectoris2
Arrhythmias, Cardiac2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.